Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high m aintenancedose clopidogrel of 150 mg/day: Results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidogrel According to Gene Polymorphism) study - Jeong, YH; Kim, IS; Park, Y (JACC Cardiovasc Interv, 2010)
et al.